How Hinge Health (IPO Oct-2025), Sword Health, Kaia Health, RecoveryOne, Vori Health, Omada, Limber, RSI, Bardavon, IncludeHealth, Vori.
AI-native digital-musculoskeletal, virtual-physical-therapy, computer-vision-motion-capture-webcam-smartphone, wearable-sensor-IMU-EMG, tablet-guided-home-exercise, tele-PT-synchronous, asynchronous-messaging, GLP-1-adjacent-weight-bearing-recovery, post-surgical-rehab-TKA-THA-ACL, chronic-low-back-neck-shoulder-hip-knee-pain, pelvic-floor, fall-prevention-Medicare-Advantage, workers-comp-return-to-work, employer-point-solution, health-plan-in-network, Medicare-Advantage-supplemental-benefit, value-based-care-shared-savings, PMPM-per-member-per-month, case-rate, episode-of-care, bundled-payment is one of the highest-signal digital-health, employer-benefits, Medicare-Advantage, workers-comp, value-based-care software categories for 2026 — validated by Hinge-Health $NYSE:HNGE-IPO-Oct-16-2025-$2.6B-valuation-priced-$32-$437M-raised, Sword-Health $3B-valuation-Jun-2024-$130M-Series-E-adj-General-Catalyst-Khosla-Comcast-Founders-Fund, Kaia-Health $260M+-raised-Optum-Ventures-3VC, Omada-Health $NASDAQ:OMDA-IPO-Jun-2025, RecoveryOne-acquired-by-Trustmark-adj, Vori-Health $61M-Series-B-Feb-2023-AlleyCorp-NEA-Google-Ventures, IncludeHealth, Limber-Health, RSI-Concentra-adj, Bardavon-Health, Physera-Omada-2020, Simple-Therapy, PhysiApp, Reflexion-Health-legacy, Nayya-adj, Included-Health-Grand-Rounds-Doctor-on-Demand, Included-Health $6B-2021, Transcarent $2.2B-Nov-2024, Virgin-Pulse-Personify-Health $3B-adj, Wellhub-Gympass $NYSE:GYM-IPO-May-2025 as the credible-scale founder-led, PBM-anchored, employer-anchored, Medicare-Advantage-anchored digital-MSK, virtual-PT stack. Founders here underwrite on clinically-validated, peer-reviewed-published-outcomes, engagement, completion, pain-reduction-VAS-Visual-Analog-Scale, PROMIS-Pain-Interference, Oswestry-Disability-Index, Neck-Disability-Index, KOOS-Knee-Injury-Osteoarthritis-Outcome-Score, HOOS-Hip, surgery-avoidance, MRI-avoidance, opioid-avoidance, return-to-work, employer-ROI-medical-cost-offset-1.5x-3x, PMPM benchmark — not vanity 'AI-for-PT' claims without a peer-reviewed RCT-randomized-controlled-trial or actuarial ROI audit.
Four unlocks: (1) Hinge-Health $NYSE:HNGE-IPO-Oct-16-2025-$2.6B, Omada $NASDAQ:OMDA-IPO-Jun-2025, Wellhub-Gympass $NYSE:GYM-IPO-May-2025 reopened the digital-health-IPO window and set public-market comps for AI-native MSK, virtual-PT, digital-therapeutics — the first credible IPO exits after the 2022-2024 digital-health-drought (Bright-Health-delisted, Cerebral-shutdown, Babylon-delisted, Better-Therapeutics-delisted, Pear-Therapeutics-bankruptcy-Apr-2023). (2) CMS-Remote-Therapeutic-Monitoring-RTM-CPT-98975-98977-98980-98981-Jan-2022, CY-2025-Physician-Fee-Schedule-Nov-2024, KX-modifier-$2,410-therapy-cap-CY-2025, Medicare-Advantage-SSBCI-Special-Supplemental-Benefits, PT-Compact-40-states-Jul-2025, MHPAEA-Final-Rule-Sep-2024, CAA-2021-fiduciary, Transparency-in-Coverage-Jul-2022, FDA-PCCP-Predetermined-Change-Control-Plan-Aug-2024 created enforceable, billable, reimbursable, fiduciary-audited rails for AI-native digital-MSK. (3) GLP-1-Ozempic-Wegovy-Mounjaro-Zepbound-Eli-Lilly-Novo-Nordisk-$50B+-2025-revenue created a $200B+ weight-loss, metabolic-health, weight-bearing-recovery adjacency — sarcopenia, bone-density, fall-prevention, post-GLP-1-weight-loss MSK-recovery is a net-new digital-MSK use-case. (4) Employer benefit-consultants, purchaser-coalitions (PBGH, BGH, HTA, Mercer, Aon, WTW, Milliman, Segal) codified performance-guarantees, at-risk-fees, shared-savings, downside-risk, full-capitation, PMPM, case-rate, episode-of-care, bundled-payment as the required commercial model — vanity PMPM without RCT, actuarial audit no longer clears diligence.
Seed $2-8M for first-employer-pilot, first-health-plan-in-network, first-Medicare-Advantage-SSBCI, first-workers-comp-panel, first-peer-reviewed publication in JMIR, Physical-Therapy-APTA, first-FDA-SaMD-Class-II-510(k), first-HIPAA-HITRUST-SOC-2-BAA, first-PT-Compact-multi-state license (Vori-Health-early, Limber-Health-early, IncludeHealth-early, RecoveryOne-early, Bardavon-early, Physera-early-Omada-2020). Series A/B/C $15-200M for national-employer-Fortune-500-count, covered-lives-1M+, health-plan-in-network UnitedHealth-Optum, Elevance, Cigna, Aetna-CVS, Humana, Kaiser, BCBS, Medicare-Advantage-CMS-Star-Rating, SSBCI, workers-comp-Concentra-Sedgwick-CorVel-Enlyte, peer-reviewed RCT, actuarial-Milliman-Mercer-audited ROI 1.5x-3x, FDA-SaMD-De-Novo, PCCP-Aug-2024, at-risk-PMPM, shared-savings (Hinge-Health $NYSE:HNGE-IPO-Oct-2025-$2.6B-$437M-raised-priced-$32, Sword-Health $3B-Jun-2024-General-Catalyst-Khosla-Comcast-Founders-Fund, Kaia-Health $260M+-Optum-Ventures-3VC, Omada $NASDAQ:OMDA-IPO-Jun-2025, Vori-Health $61M-Series-B-Feb-2023-AlleyCorp-NEA-Google-Ventures, Transcarent $2.2B-Nov-2024, Included-Health $6B-2021, Devoted-Health $12.6B-2021). Growth, IPO, PE, strategic $200M-$10B+ (Hinge $NYSE:HNGE, Omada $NASDAQ:OMDA, Wellhub-Gympass $NYSE:GYM, Teladoc $NYSE:TDOC, Amwell $NYSE:AMWL, Hims-Hers $NYSE:HIMS, Signify-Health-CVS-$8B-2023, One-Medical-Amazon-$3.9B-2023, Oak-Street-Health-CVS-$10.6B-2023, Livongo-Teladoc-$18.5B-2020). Non-dilutive material — SBIR-NIH-HHS-CDC, BARDA-HRSA, PCORI-Patient-Centered-Outcomes-Research-Institute, AHRQ-Agency-Healthcare-Research-Quality, NIH-NIA-NIMHD-NCCIH, CMS-Innovation-Center-CMMI, Medicare-Advantage-Star-Rating-CMS-Value-Based-Insurance-Design-VBID, ARPA-H.
Overclaiming engagement, completion, pain-reduction, surgery-avoidance, MRI-avoidance, opioid-avoidance, return-to-work, employer-ROI without peer-reviewed RCT in JAMA-Network-Open, NEJM-Catalyst, JMIR, Physical-Therapy-APTA, Nature-Digital-Medicine, actuarial-Milliman-Mercer-Aon-WTW-Deloitte-Segal-audit, employer-purchaser-coalition-PBGH-BGH-HTA-validated, FDA-SaMD-De-Novo-510(k)-PCCP-cleared, HIPAA-HITRUST-SOC-2-BAA-audited track-record — post-Hinge-$NYSE:HNGE-IPO-Oct-2025, post-Omada-$NASDAQ:OMDA-IPO-Jun-2025, post-Sword-$3B, post-Pear-Therapeutics-bankruptcy-Apr-2023, post-Better-Therapeutics-delisted, post-Bright-Health-delisted, post-Cerebral-shutdown, post-Babylon-delisted, post-Change-Healthcare-Feb-2024-breach, post-MHPAEA-Final-Rule-Sep-2024, post-CAA-2021, post-CMS-RTM-CPT-98975-98981, post-PT-Compact-40-states-Jul-2025 credible-scale bar, operators without a peer-reviewed RCT, actuarial-audited ROI, Fortune-500 or health-plan or Medicare-Advantage or workers-comp anchor, FDA-SaMD, HIPAA-HITRUST-SOC-2, PT-Compact multi-state license track-record get flagged by General-Catalyst, a16z-Bio+Health, Founders-Fund, Khosla, Insight, Tiger, Coatue, Bessemer, Bond, Redpoint, NEA, AlleyCorp, GV, Optum-Ventures, 7wireVentures, Oak-HC/FT, F-Prime, Bain-Capital-Ventures, Frist-Cressey, Elevance-Cigna-CVS-UnitedHealth-Humana-Kaiser diligence within 12-18 months. Underestimating FDA-SaMD, De-Novo, 510(k), PCCP-Aug-2024, AI-ML-Action-Plan-Jan-2021, GMLP-Oct-2021, FDA-Draft-Life-Cycle-Guidance-Jan-2025, HIPAA-HITECH-Omnibus, HITRUST-CSF-v11, SOC-2-Type-II, BAA, PHI-de-identification, OCR-audit, breach-notification, Change-Healthcare-Feb-2024, CMS-RTM-CPT-98975-98977-98980-98981, RPM-CPT-99453-99458, PT-CPT-97110-97530, telehealth-Modifier-95-93, CY-2025-Physician-Fee-Schedule, KX-modifier-$2,410-therapy-cap, Medicare-Advantage-SSBCI, CMS-Star-Rating, MACRA-MIPS-APM-ACO-REACH, ERISA-preemption, MHPAEA-2008-Final-Rule-Sep-2024, CAA-2021, Transparency-in-Coverage-MRF-Jul-2022, PT-Compact-40-states-Jul-2025, IMLC-40+states, PSYPACT, NLC, DEA-Ryan-Haight-in-person-exam-extended-Dec-31-2025, controlled-substance-telehealth-final-rule-2025 regulatory, compliance.
Investor directory · Fundraising library · Articles A–Z · Company funding database